May 13, 2021
GENFIT: Reports First Quarter 2021 Financial Information
(Unaudited financial information under IFRS) Cash and cash equivalents totaled €109 million as of March 31, 2021 Lille, France; Cambridge,…
Pharmaceuticals, Biotechnology and Life Sciences
(Unaudited financial information under IFRS) Cash and cash equivalents totaled €109 million as of March 31, 2021 Lille, France; Cambridge,…
FREMONT, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for…
Cash and Cash Equivalents of $36.6M, More Than Sufficient to Fund Completion of the Current Clinical Trials of Lead Drug…
– Announces IND Authorization by FDA for Fadraciclib, a CDK2/9 Inhibitor, in Solid Tumors – – Recent Publication Reported that Overactive…
SEATTLE, May 12, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development…
DURHAM, N.C., May 12, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in…
BASKING RIDGE, NJ, May 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE…
EXTON, Pa., May 11, 2021 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO)…
PARIS, May 11, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – Euronext Growth: ALCLS), a clinical-stage biotechnological company employing…
U.S. IXPLORE Phase II trial achieved its objective; vilobelimab was shown to be safe and well tolerated in patients with…